Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Clinical Trials
373 Articles Available
1
16
Can't find what you're looking for? Try our
advanced search
.
Phase III
GSK Announces Positive Headline Results in Phase 3 PRIMA Study of ZEJULA (niraparib) For Patients with Ovarian Cancer
PR-M07-19-NI-039
ViiV Healthcare Announces Phase III Study Meets Primary Endpoint
PR-M07-19-NI-032
Drug Development
New Drug for Duchenne Muscular Dystrophy (DMD) Shows Promise
PAO-M07-19-NI-010
Phase III
Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression
PR-M07-19-NI-023
Clinical Study
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study
PR-M07-19-NI-024
Biosimilar
Prestige BioPharma Releases Positive Results from Phase I Study of HD204, Biosimilar Candidate to Bevacizumab
PR-M07-19-NI-020
Clinical Data
Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD)
PR-M07-19-NI-017
Phase II
Iovance Biotherapeutics Provides Cervical Cancer Program Updates Following End of Phase 2 Meeting with U.S. Food and Drug Administration (FDA)
PR-M07-19-NI-016
Clinical Trials
FDA Provides Guidance on Increasing Clinical Trial Diversity
PAO-M07-19-NI-003
Oncology
Imfinzi Improves Survival in the Phase III CASPIAN Trial in 1st-line Extensive-stage Small Cell Lung Cancer
PR-M07-19-NI-003
Clinical Trials
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial and Receives Regenerative Medicine Advanced Therapy Designation
PR-M06-19-NI-047
Trial Recruitment
SubjectWell Raises $10M to Expand Its Risk-Free Patient Recruitment Marketplace
PR-M06-19-NI-040
Clinical Data
Enanta Pharmaceuticals Announces Positive Topline Results in Healthy Adults Infected with Respiratory Syncytial Virus (RSV)
PR-M06-19-NI-028
Clinical Trials
GBT Announces Efficacy Data from All Patients Enrolled in Phase 3 Study Sustained Improvements in Hemoglobin with Voxelotor
PR-M06-19-NI-025
Drug Development
Over 1000 Cancer Cell Therapies in Development
PAO-M06-19-NI-003
Launch
TrialAssure Launches TrialResults.com for Clinical Trial Sponsors to Publicly Post Plain Language Summaries
PR-M06-19-NI-010
Vaccine
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
PR-M05-19-NI-074
Clinical Trials
Respivant Sciences Announces Dosing of First Patient in Phase 2b Trial of RVT-1601 for the Treatment of Persistent Cough Due to Idiopathic Pulmonary Fibrosis
PR-M05-19-NI-075
Biological Materials
Keys to Successful Storage, Management and Transport of Biological Materials
PAP-Q2-2019-CL-035
Clinical Trials
BBK Worldwide Opens Latest Subsidiary, Strengthening Global Clinical Trial Patient Support Initiatives
PR-M05-19-NI-072
Endpoint
Array Biopharma Announces Braftovi + Mektovi + Cetuximab Meet Primary Endpoints in Metastatic Colorectal Cancer
PR-M05-19-NI-069
Phase I Study
Painting Tumors Is a Promising Approach to Improve Surgical Outcomes
PAO-M05-19-NI-024
Clinical Trial Data
Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting
PR-M05-19-NI-060
Pfizer Announces Positive Top-Line Results from Phase 3 Study in Patients with Moderate to Severe Atopic Dermatitis
PR-M05-19-NI-055
1
16
»
